We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

1 hedge funds and large institutions have $3K invested in GW Pharmaceuticals Plc American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 294 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 297 → 1 (-296)

100% less funds holding in top 10

Funds holding in top 10: 21 → 0 (-21)

100% less capital invested

Capital invested by funds: $5.23B → $3K (-$5.23B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 294

Holders
1
Holders Change
-296
Holders Change %
-99.66%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-21
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
294
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
-$456M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$325M
3
HI
HBK Investments
Texas
-$292M
4
FCM
Farallon Capital Management
California
-$277M
5
GCL
Glazer Capital LLC
New York
-$212M
Name Holding Trade Value Shares
Change 		Change in
Stake
VRM
276
Vectors Research Management
New York
– -$5K -24 Closed
MFA
277
McClarren Financial Advisors
Pennsylvania
– -$4K -18 Closed
KFS
278
Kelly Financial Services
Massachusetts
– -$3.69K -17 Closed
GWSG
279
GPS Wealth Strategies Group
Colorado
– -$2K -13 Closed
AF
280
Allworth Financial
California
– -$3K -12 Closed
PA
281
Perennial Advisors
New York
– -$3K -12 Closed
CHC
282
City Holding Co
West Virginia
– -$2K -10 Closed
PP
283
Pacifica Partners
Canada
– -$2K -10 Closed
PA
284
Parallel Advisors
California
– -$2K -7 Closed
AWM
285
Avior Wealth Management
Nebraska
– -$1K -6 Closed
HR
286
Howe & Rusling
New York
– -$1K -5 Closed
MWM
287
Mascoma Wealth Management
New Hampshire
– -$1K -5 Closed
WAS
288
Winch Advisory Services
Wisconsin
– -$1K -5 Closed
BFC
289
Bedel Financial Consulting
Indiana
– -$1K -4 Closed
CCC
290
Crescent Capital Consulting
Louisiana
– -$1K -4 Closed
VNA
291
Valley National Advisers
Pennsylvania
– -$1K -3 Closed
8 9 10 11
12

GWPH Hedge Fund Activity: Q2 2021 in Review

1 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2021, worth a combined $3K — down 100% from $5.23B a quarter earlier.

Sellers outnumbered buyers: 294 funds closed out of GWPH and 0 opened new positions — a net loss of 294 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Pentwater Capital Management, exiting entirely with an estimated $456M sold.

  • 1 institutional investor held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2021, down from 297 in Q1 2021.
  • Funds reported $3K of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2021 and 294 closed out, a net change of -294 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2021 was Pentwater Capital Management, an estimated $456M sold.

Based on aggregated 13F filings for Q2 2021.